Benitec Biopharma Ltd ADR (BNTC) — Capital Reinvestment Ratio
Latest as of September 2018:
0.00x
Benitec Biopharma Ltd ADR (BNTC) has a Capital Reinvestment Ratio of 0.00x as of September 2018, meaning it reinvests 0% of its operating cash flow ($5.87 Million) in capital expenditures ($26.00K). See cash generation quality of Benitec Biopharma Ltd ADR to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$5.87 Million
USD
Capital Expenditures
$26.00K
USD
Data as of
Sep 2018
Most recent filing
Benitec Biopharma Ltd ADR Capital Reinvestment Ratio (2019–2019)
This chart tracks Benitec Biopharma Ltd ADR's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Benitec Biopharma Ltd ADR (2019–2019)
Year-by-year Capital Reinvestment Ratio for Benitec Biopharma Ltd ADR from 2019 to 2019. For live market cap and broader valuation context, see Benitec Biopharma Ltd ADR market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.08x | $4.79 Million | $403.40K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow